Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.



Joseph LaPlume
Joseph W. LaPlume
Corporate Executive Vice President, Corporate Development & Strategy

Joseph W. LaPlume joined Charles River in 2005, was named the Company’s Corporate Senior Vice President, Corporate Development in 2014, and promoted to Corporate Executive Vice President, Corporate Development & Strategy in 2019. Mr. LaPlume is responsible for strategic acquisitions and expanding the Company’s portfolio and geographic footprint. Mr. LaPlume was promoted from Corporate Vice President, Corporate Development, a position that he held from 2011, and has been instrumental in enhancing the Company’s growth profile through several acquisitions and multiple licensing transactions. Mr. LaPlume was formerly Deputy General Counsel at Charles River, and began his career at Charles River as a corporate lawyer in 2005. Prior to joining Charles River, Mr. LaPlume had extensive experience in both corporate law and mergers and acquisitions at Mintz Levin, Goulston & Storrs, and GTECH Corporation.

Mr. LaPlume received M.B.A. and J.D. degrees from Boston University, and Bachelor’s degree from Trinity College.

    Featured Report

    2020 Annual Report (PDF)

    Charles River Corporate Citizenship Report
    View PDF
    Print PDF